| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |